Evaluation and Management of Nonculprit Lesions in STEMI

Troels Thim; Nina W van der Hoeven; Carmine Musto; Robin Nijveldt; Matthias Götberg; Thomas Engstrøm; Pieter C Smits; Keith G Oldroyd; Anthony H Gershlick; Javier Escaned; Sergio Bravo Baptista; Luis Raposo; Niels van Royen; Michael Maeng

doi:10.1016/j.jcin.2020.02.030

Evaluation and Management of Nonculprit Lesions in STEMI

Troels Thim, Nina W van der Hoeven, Carmine Musto, Robin Nijveldt, Matthias Götberg, Thomas Engstrøm, Pieter C Smits, Keith G Oldroyd, Anthony H Gershlick, Javier Escaned, Sergio Bravo Baptista, Luis Raposo, Niels van Royen, Michael Maeng

Afdeling for Hjertesygdomme HJE

48 Citationer (Scopus)

Abstract

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

Originalsprog	Engelsk
Tidsskrift	JACC: Cardiovascular Interventions
Vol/bind	13
Udgave nummer	10
Sider (fra-til)	1145-1154
Antal sider	10
ISSN	1936-8798
DOI	https://doi.org/10.1016/j.jcin.2020.02.030
Status	Udgivet - 25 maj 2020

Adgang til dokumentet

10.1016/j.jcin.2020.02.030

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{213081dbf2984c1e861a2264f4987355,

title = "Evaluation and Management of Nonculprit Lesions in STEMI",

abstract = "Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.",

keywords = "Clinical Decision-Making, Coronary Artery Disease/diagnostic imaging, Coronary Circulation, Coronary Stenosis/diagnostic imaging, Humans, Percutaneous Coronary Intervention/adverse effects, Recovery of Function, Recurrence, Risk Factors, ST Elevation Myocardial Infarction/diagnostic imaging, Severity of Illness Index, Treatment Outcome",

author = "Troels Thim and \{van der Hoeven\}, \{Nina W\} and Carmine Musto and Robin Nijveldt and Matthias G{\"o}tberg and Thomas Engstr{\o}m and Smits, \{Pieter C\} and Oldroyd, \{Keith G\} and Gershlick, \{Anthony H\} and Javier Escaned and Baptista, \{Sergio Bravo\} and Luis Raposo and \{van Royen\}, Niels and Michael Maeng",

year = "2020",

month = may,

day = "25",

doi = "10.1016/j.jcin.2020.02.030",

language = "English",

volume = "13",

pages = "1145--1154",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Evaluation and Management of Nonculprit Lesions in STEMI

AU - Thim, Troels

AU - van der Hoeven, Nina W

AU - Musto, Carmine

AU - Nijveldt, Robin

AU - Götberg, Matthias

AU - Engstrøm, Thomas

AU - Smits, Pieter C

AU - Oldroyd, Keith G

AU - Gershlick, Anthony H

AU - Escaned, Javier

AU - Baptista, Sergio Bravo

AU - Raposo, Luis

AU - van Royen, Niels

AU - Maeng, Michael

PY - 2020/5/25

Y1 - 2020/5/25

N2 - Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

AB - Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

KW - Clinical Decision-Making

KW - Coronary Artery Disease/diagnostic imaging

KW - Coronary Circulation

KW - Coronary Stenosis/diagnostic imaging

KW - Humans

KW - Percutaneous Coronary Intervention/adverse effects

KW - Recovery of Function

KW - Recurrence

KW - Risk Factors

KW - ST Elevation Myocardial Infarction/diagnostic imaging

KW - Severity of Illness Index

KW - Treatment Outcome

UR - https://www.scopus.com/pages/publications/85084345472

U2 - 10.1016/j.jcin.2020.02.030

DO - 10.1016/j.jcin.2020.02.030

M3 - Review

C2 - 32438985

SN - 1936-8798

VL - 13

SP - 1145

EP - 1154

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 10

ER -

Evaluation and Management of Nonculprit Lesions in STEMI

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater